
United States · Biopharma startup
Altos Labs focuses on cellular rejuvenation programming to restore cell health and resilience, to reverse disease to transform medicine.
Funding reportedLast round: Series A
Funding, as reported
From Altos Labs's own website: 3 founders, 9 on the team.
AdvisersRick Klausner
Add your raise, your deck and your story, and put Altos Labs in front of investors. Or tell us what we have wrong.